clinical trials

Acceleron blood disease drug hits goal in pivotal clinical trial
Acceleron blood disease drug hits goal in pivotal clinical trial
Stat
Acceleron
Celgene
luspatercept
clinical trials
myelodysplastic syndrome
Flag link:
GBT touts positive sickle cell trial, but shares yo-yo as investors mull data
GBT touts positive sickle cell trial, but shares yo-yo as investors mull data
Fierce Biotech
Global Blood Therapeutics
sickle cell disease
voxelotor
clinical trials
Flag link:
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure
Xconomy
Summit Therapeutics
ezutromid
clinical trials
Duchenne Muscular Dystrophy
Flag link:
With the ink on their $25M Astellas deal still drying, Aquinox shares get blasted on PhIII failure
With the ink on their $25M Astellas deal still drying, Aquinox shares get blasted on PhIII failure
Endpoints
Aquinox Pharmaceuticals
Astellas
rosiptor
Asia
clinical trials
Interstitial Cystitis
Flag link:
Purdue Pharma Completes Ph I for Oncology Therapy Candidate
Purdue Pharma Completes Ph I for Oncology Therapy Candidate
CP Wire
Purdue Pharma
clinical trials
tinostamustine
hematologic cancers
Flag link:
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
ALS drug maker walks back plan to profit from right-to-try law following heavy criticism
Stat
BrainStorm Cell Therapeutics
right-to-try laws
ALS
clinical trials
NurOwn
Flag link:
Sudden death forces Sophiris to halt followup therapy in prostate cancer study — shares crushed
Sudden death forces Sophiris to halt followup therapy in prostate cancer study — shares crushed
Endpoints
Sophris
prostate cancer
Topsalysin
clinical trials
Flag link:
Pfizer's breast cancer drug combo falls short of survival goal
Pfizer's breast cancer drug combo falls short of survival goal
Yahoo/Reuters
Pfizer
breast cancer
Ibrance
clinical trials
Flag link:
With latest data, has Roche's Tecentriq found a blockbuster lung cancer niche?
With latest data, has Roche's Tecentriq found a blockbuster lung cancer niche?
Fierce Pharma
Roche
Tecentriq
clinical trials
small cell lung cancer
Flag link:
Controversial researcher’s diabetes vaccine causes improvement in small study
Controversial researcher’s diabetes vaccine causes improvement in small study
Stat
type 1 diabetes
diabetes
clinical trials
insulin
vaccines
Organon Teknika
Flag link:
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
CP Wire
OncBioMune
ProscaVax
prostate cancer
vaccines
clinical trials
Flag link:
With tantalizing early results, Sarepta’s gene therapy for Duchenne raises hopes for ‘real change’
With tantalizing early results, Sarepta’s gene therapy for Duchenne raises hopes for ‘real change’
Stat
Sarepta Therapeutics
Duchenne Muscular Dystrophy
clinical trials
Flag link:
After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom
After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom
Endpoints
Cytokinetics
clinical trials
reldesemtiv
Tirasemtiv
spinal muscular atrophy
Astellas
Flag link:
BioMarin Begins Pediatric Study on Achondroplasia Candidate
BioMarin Begins Pediatric Study on Achondroplasia Candidate
Yahoo/Zacks.com
Biomarin
clinical trials
vosoritide
achrondoplasia
Flag link:
Lilly's lupus treatment succeeds in mid-stage trial
Lilly's lupus treatment succeeds in mid-stage trial
Reuters
Eli Lilly
lupus
olumiant
baricitinib
clinical trials
Flag link:
Galmed stock jumps sky-high on mixed results for NASH drug
Galmed stock jumps sky-high on mixed results for NASH drug
Biopharma Dive
Galmed Pharmaceuticals
clinical trials
NASH
aramchol
Flag link:
ViiV Healthcare reports positive results for late-stage HIV trials
ViiV Healthcare reports positive results for late-stage HIV trials
Marketwatch
ViiV Healthcare
GSK
Pfizer
Shionogi
HIV
clinical trials
Dolutegravir
lamivudine
Flag link:
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
CP Wire
Advaxis
ADXS-NEO
immunotherapy
non-small cell lung cancer
clinical trials
Flag link:
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant
Eisai, Purdue reveal eye-opening data for sleep drug lemborexant
Fierce Biotech
Eisai
Purdue Pharma
lemborexant
sleep disorders
clinical trials
insomnia
Flag link:
Madrigal Pharma shares skyrocket 145% on positive results for liver disease therapy
Madrigal Pharma shares skyrocket 145% on positive results for liver disease therapy
Marketwatch
Madrigal Pharmaceuticals
NASH
clinical trials
MGL-3196
Flag link:

Pages